Browsing: Clinical Mortality
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for clinical mortality analysis, commentary and insights.
Those still trying to understand any potential future impact of Covid-19 on mortality are conducting an exercise in futility.
Recent months have delivered two significant developments that could profoundly impact life expectancy for those with chronic kidney disease.
A new paper from Klarity and Munich Life Re US has examined physical activity data from wearable technology and tied this data to mortality risk.
Those advising insurance companies and pension schemes on mortality are paying very close attention to developments with anti-obesity medicines.
The outlook for metastatic melanoma continues to improve, driven by advancements in therapeutic strategies and ongoing research.
New research suggests that the chances then that the next 100 years or so brings about a similar jump?
It could take decades for the new legislation to have any discernible impact on mortality.
While ageing is fundamentally a physiological phenomenon, numerous factors significantly influence the rate at which this process occurs. Certain factors can accelerate the ageing process, while some have the potential to decelerate it, influencing the rate of physiological decline.
New technological advances to meet key healthcare needs are a crucial element driving the performance profile of the healthcare sector.
US life expectancy gap to other developed countries has widened in the past two years.